We are live on
!
Find out more
Lineage Cell Therapeutics
LCTX
LCTX
92 hedge funds and large institutions have $146M invested in Lineage Cell Therapeutics in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 14 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 3
157% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 14
15% more funds holding
Funds holding: 80 → 92 (+12)
1.35% more ownership
Funds ownership: 43.4% → 44.75% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $152M → $146M (-$6.22M)
13% less call options, than puts
Call options by funds: $127K | Put options by funds: $146K
Holders
92
Holders Change
+12
Holders Change %
+15%
% of All Funds
2.3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
36
Reduced
14
Closed
3
Calls
$127K
Puts
$146K
Net Calls
-$19K
Net Calls Change
+$196K
